Dr. Andrea Nicolette Manhart D. O,

Recommended Articles

• Woman with Multiple Sclerosis Lives Her Dream

  When a person is first diagnosed with a chronic, progressive condition like multiple sclerosis, it can be hard to look ahead to the rest of life and have a positive outlook. Moving forward in life and adapting to the change is that much more difficult with the knowledge that the condition will cause...

• Neuroprotection: New Possible Treatment for Multiple Sclerosis

  Researchers are continuously uncovering new ways to help cure multiple sclerosis (MS). One area in particular that shows promising results is neuroprotection. Neuroprotection aims to prevent nerve cells from becoming damaged, thus slowing down the progression of the disease. Initially, MS symptoms...

• Helping a Loved One Cope with Depression

  Depression is a serious mood disorder that can really change the way people live their life. However, depression can be treated with the help and support of people who truly care about the welfare of a person who is depressed. Most people who frequently feel depressed need intervention and treatment...

• What Is Akathisia and How to Treat It?

  What is akathisia?Akathisia is a medical condition that causes an individual to feel restless along with a constant urge to move. The term akathisia is derived from the Greek word akathemi, which would mean "to never sit down".Akathisia occurs as a side effect of first-generation or older...

• What Is a Transient Ischemic Attack (TIA)?

  OverviewA transient ischemic attack (TIA) is a mini-stroke, which only lasts for a few minutes. It occurs when blood stops flowing to a part of the brain for a short time. The symptoms of TIA are similar to other symptoms of stroke, but they do not last long, so TIA does not lead to permanent...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...